A detailed history of Sierra Summit Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 380,038 shares of PFE stock, worth $10 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares
380,038
Previous 349,690 8.68%
Holding current value
$10 Million
Previous $9.78 Billion 12.41%
% of portfolio
2.53%
Previous 2.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $840,639 - $952,623
30,348 Added 8.68%
380,038 $11 Billion
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $416,082 - $487,571
16,472 Added 4.94%
349,690 $9.78 Billion
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $8.44 Million - $9.69 Million
325,949 Added 4484.1%
333,218 $9.25 Billion
Q4 2023

Feb 22, 2024

BUY
$26.13 - $33.94 $189,938 - $246,709
7,269 New
7,269 $209 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sierra Summit Advisors LLC Portfolio

Follow Sierra Summit Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Summit Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Summit Advisors LLC with notifications on news.